SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge (2022)
Attributed to:
A reverse vaccinology approach to a bTB vaccine
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/v14050914
PubMed Identifier: 35632656
Publication URI: http://europepmc.org/abstract/MED/35632656
Type: Journal Article/Review
Parent Publication: Viruses
Issue: 5
ISSN: 1999-4915